Jane Reynolds Salois

She has been a medical speech-language pathologist since 2015 practicing primarily in hospital and outpatient settings. Her specialty areas include the assessment and treatment of voice, upper airway, and swallowing disorders. She is passionate about clinical education and mentorship of speech language pathologists in voice and upper airway disorders, as well as discovering innovative ways to deliver evidence-based, person-centered, and culturally responsive care to individuals in rural and historically underserved areas.

Her research has been funded by the National Institutes of Health (National Institute of General Medical Sciences) through the University of Montana’s Center for Population Health Research. In a pilot study, she developed and tested Internet-based Behavioral Cough Suppression Therapy in a randomized, sham-treatment controlled trial, and conducted a qualitative analysis to understand patients’ experiences. Hyfe AI was involved in this project with longitudinal cough frequency monitoring. She co-directs the VoiceOutcomes and Essentials in Swallowing (VOICES) Lab with Dr. Laurie Slovarp with ongoing projects evaluating the efficacy of telehealth group behavioral cough suppression therapy, and a retrospective study examining the effectiveness of a behavioral cough suppression therapy intervention that emphasizes the principles of neuroplasticity. She is fascinated by the psychology of cough and neuroscientific underpinnings of cough hypersensitivity syndrome, and is passionate about translating scientific knowledge into practical, effective, and compassionate care—especially in rural and historically underserved populations. Her experiences working with and learning from patients continue to inspire her research and drive her enthusiasm for contributing to the Hyfe AI team and its mission. Dr. Salois has contributed to over 11 peer-reviewed manuscripts related to refractory chronic cough and frequently presents at national conferences